Aclaris Therapeutics Inc. (ACRS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Aclaris Therapeutics Inc.

NASDAQ: ACRS · Real-Time Price · USD
1.99
0.12 (6.42%)
At close: Sep 26, 2025, 3:59 PM
1.98
-0.50%
After-hours: Sep 26, 2025, 06:21 PM EDT

Aclaris Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
24.57M 39.88M 45.28M 27.35M
Short-Term Investments
89.02M 79.23M 172.29M 164.06M
Long-Term Investments
90.3M 62.77M 12.24M 34.24M
Other Long-Term Assets
3.07M 3.89M -630K 3.55M
Receivables
318K 298K 484K 623K
Inventory
n/a n/a -12.24M n/a
Other Current Assets
12.04M 9.45M 25.74M n/a
Total Current Assets
125.95M 128.86M 231.55M 205.03M
Property-Plant & Equipment
1.01M 1.62M 1.1M 1.33M
Goodwill & Intangibles
n/a 269K 6.97M 7.05M
Total Long-Term Assets
94.38M 68.55M 23.05M 46.18M
Total Assets
220.33M 197.41M 254.6M 251.21M
Account Payables
4.69M 8.88M 10.35M 9.98M
Deferred Revenue
3.89M n/a n/a 10.05M
Short-Term Debt
481K 426K 684K 693K
Other Current Liabilities
22.05M 10.37M 6.81M -4.15M
Total Current Liabilities
31.6M 30.95M 21.94M 22.93M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
11.02M 6.2M 34.67M 30.57M
Total Long-Term Liabilities
33.18M 9.27M 35.04M 30.94M
Total Liabilities
64.77M 40.23M 56.98M 53.87M
Total Debt
2.6M 3.5M 2.25M 2.89M
Book Value
155.55M 157.18M 197.62M 197.34M
Book Value Per Share
2.01 2.25 3.03 3.48
Common Stock
1K 1K 1K 1K
Retained Earnings
-902.86M -770.8M -682.32M -595.41M
Comprehensive Income
97K -106K -897K -224K
Shareholders Equity
155.55M 157.18M 197.62M 197.34M
Total Investments
179.33M 142M 184.54M 198.31M